Newsroom
← Older postsCORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to be held on May 23rd
CAMBRIDGE, Mass. (May 21, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company will be conducting a webcast of the Annual Shareholders Meeting scheduled for Thursday, May 23, 2013 at 10:00 a.m. Eastern Daylight Time [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
Interview with InVivo Therapeutics’ CEO to be Aired on Boston’s NPR Station WBUR This Morning
CAMBRIDGE, Mass. (May 21, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that an interview with InVivo Chief Executive Officer Frank Reynolds is scheduled to be aired on WBUR in Boston this morning during Morning Edition with [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to be held on May 23th
CAMBRIDGE, Mass. (May 17, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company will be conducting a webcast of the Annual Shareholders Meeting scheduled for Thursday, May 23, 2013 at 10:00 a.m. Eastern Daylight Time at the offices [...]
Posted in Investor Relations, Press Releases | Leave a comment
InVivo Therapeutics Sponsors 8th Annual Working 2 Walk Spinal Cord Injury Symposium
CAMBRIDGE, Mass. (May 16, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update
CAMBRIDGE, Mass. (May 9, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported financial results for the three months ended March 31, 2013 and provided a business update. InVivo has pioneered a new treatment platform utilizing a variety [...]
Posted in Financials, Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics Announces Call Notice for Exercise of Warrants and Partial Termination of Warrant Exchange Offer
CAMBRIDGE, Mass. (May 3, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that it has issued a call notice for the early exercise of warrants issued to investors on October 26, 2010, November 10, 2010 and December [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics Named a 2013 “Best Places to Work” Winner by Boston Business Journal
CAMBRIDGE, Mass. (May 2, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company has been named one of the Best Places to Work in Massachusetts by the The Boston Business Journal in its eleventh annual [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics’ CEO Scheduled to Appear on FOX Business Network’s “Varney & Company”
CAMBRIDGE, Mass. (April 29, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that CEO Frank Reynolds is scheduled to appear live in New York City on FOX Business Network’s “Varney & Company” on Tuesday, April 30th at [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Therapeutics’ CEO Scheduled to Appear on Business News Network’s “The Close” in Canada
CAMBRIDGE, Mass. (April 26, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of neurotrauma conditions, today announced that CEO Frank Reynolds is scheduled to appear live in Toronto on Business News Network’s (BNN–TV) “The Close” on Monday, April 29th at approximately 4:50pm ET. BNN is Canada’s only all [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment
InVivo Enters Commercialization Phase, Adds John A. McCarthy to Board of Directors
CAMBRIDGE, Mass. (April 23, 2013) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that John A. McCarthy, Chief Executive Officer at CryoXtract, has joined InVivo’s Board of Directors. McCarthy has also been appointed as Chair of the Board’s [...]
Posted in Investor Relations, Newsroom, Press Releases | Leave a comment ← Older posts